CN101040907B - 扶正化瘀植物药中丹参原料指纹图谱质量检测方法 - Google Patents
扶正化瘀植物药中丹参原料指纹图谱质量检测方法 Download PDFInfo
- Publication number
- CN101040907B CN101040907B CN2007100401416A CN200710040141A CN101040907B CN 101040907 B CN101040907 B CN 101040907B CN 2007100401416 A CN2007100401416 A CN 2007100401416A CN 200710040141 A CN200710040141 A CN 200710040141A CN 101040907 B CN101040907 B CN 101040907B
- Authority
- CN
- China
- Prior art keywords
- acid
- peak
- tanshin polyphenolic
- quality
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 14
- 239000003814 drug Substances 0.000 title claims description 11
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 title claims description 10
- 239000002994 raw material Substances 0.000 title claims description 10
- 241000196324 Embryophyta Species 0.000 title claims description 9
- 241000304195 Salvia miltiorrhiza Species 0.000 title description 7
- 239000002253 acid Substances 0.000 claims abstract description 44
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N tanshinone IIA Natural products C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 claims abstract description 25
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical group C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 claims abstract description 14
- HYXITZLLTYIPOF-UHFFFAOYSA-N Tanshinone II Natural products O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1C(C)=CO2 HYXITZLLTYIPOF-UHFFFAOYSA-N 0.000 claims abstract description 13
- AZEZEAABTDXEHR-UHFFFAOYSA-M sodium;1,6,6-trimethyl-10,11-dioxo-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-2-sulfonate Chemical group [Na+].C12=CC=C(C(CCC3)(C)C)C3=C2C(=O)C(=O)C2=C1OC(S([O-])(=O)=O)=C2C AZEZEAABTDXEHR-UHFFFAOYSA-M 0.000 claims abstract description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 11
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 claims abstract description 9
- GVKKJJOMQCNPGB-UHFFFAOYSA-N Cryptotanshinone Natural products O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1C(C)CO2 GVKKJJOMQCNPGB-UHFFFAOYSA-N 0.000 claims abstract description 7
- GVKKJJOMQCNPGB-JTQLQIEISA-N Cryptotanshinone Chemical group O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1[C@@H](C)CO2 GVKKJJOMQCNPGB-JTQLQIEISA-N 0.000 claims abstract description 7
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 claims abstract description 7
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 claims abstract description 7
- 244000132619 red sage Species 0.000 claims abstract 8
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 claims abstract 5
- 240000007164 Salvia officinalis Species 0.000 claims description 58
- 235000005412 red sage Nutrition 0.000 claims description 40
- 235000017276 Salvia Nutrition 0.000 claims description 17
- 230000014759 maintenance of location Effects 0.000 claims description 17
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 15
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 claims description 11
- 238000010828 elution Methods 0.000 claims description 9
- PAFLSMZLRSPALU-MRVPVSSYSA-N (2R)-3-(3,4-dihydroxyphenyl)lactic acid Chemical compound OC(=O)[C@H](O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-MRVPVSSYSA-N 0.000 claims description 8
- ZXKXJHAOUFHNAS-FVGYRXGTSA-N (S)-fenfluramine hydrochloride Chemical compound [Cl-].CC[NH2+][C@@H](C)CC1=CC=CC(C(F)(F)F)=C1 ZXKXJHAOUFHNAS-FVGYRXGTSA-N 0.000 claims description 8
- PAFLSMZLRSPALU-QMMMGPOBSA-N Danshensu Natural products OC(=O)[C@@H](O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-QMMMGPOBSA-N 0.000 claims description 8
- PAFLSMZLRSPALU-UHFFFAOYSA-N Salvianic acid A Natural products OC(=O)C(O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-UHFFFAOYSA-N 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 8
- 238000005728 strengthening Methods 0.000 claims description 7
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 claims description 5
- 229940074360 caffeic acid Drugs 0.000 claims description 5
- 235000004883 caffeic acid Nutrition 0.000 claims description 5
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 claims description 5
- 238000001514 detection method Methods 0.000 claims description 5
- 229930004069 diterpene Natural products 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- IBGBGRVKPALMCQ-UHFFFAOYSA-N 3,4-dihydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1O IBGBGRVKPALMCQ-UHFFFAOYSA-N 0.000 claims description 4
- 150000007513 acids Chemical class 0.000 claims description 4
- 239000013558 reference substance Substances 0.000 claims description 4
- SOXUSBQFIOBYJU-VPIXDIMLSA-N (2r)-2-[(e)-3-[2-[(e)-3-[(1r)-1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-1-(3,4-dihydroxyphenyl)-3-oxoprop-1-en-2-yl]-3,4-dihydroxyphenyl]prop-2-enoyl]oxy-3-(3,4-dihydroxyphenyl)propanoic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C(=C(O)C(O)=CC=1)\C(=C/C=1C=C(O)C(O)=CC=1)C(=O)O[C@H](CC=1C=C(O)C(O)=CC=1)C(O)=O)C1=CC=C(O)C(O)=C1 SOXUSBQFIOBYJU-VPIXDIMLSA-N 0.000 claims description 3
- HARGZZNYNSYSGJ-UHFFFAOYSA-N 1,2 dihydrotanshinquinone Natural products C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)CO1 HARGZZNYNSYSGJ-UHFFFAOYSA-N 0.000 claims description 3
- HARGZZNYNSYSGJ-JTQLQIEISA-N Dihydrotanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2[C@@H](C)CO1 HARGZZNYNSYSGJ-JTQLQIEISA-N 0.000 claims description 3
- YMGFTDKNIWPMGF-QHCPKHFHSA-N Salvianolic acid A Natural products OC(=O)[C@H](Cc1ccc(O)c(O)c1)OC(=O)C=Cc2ccc(O)c(O)c2C=Cc3ccc(O)c(O)c3 YMGFTDKNIWPMGF-QHCPKHFHSA-N 0.000 claims description 3
- YMGFTDKNIWPMGF-UCPJVGPRSA-N Salvianolic acid A Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C(=C(O)C(O)=CC=1)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 YMGFTDKNIWPMGF-UCPJVGPRSA-N 0.000 claims description 3
- UMPZKDHDIZUVTO-UHFFFAOYSA-N Salvianolic acid D Natural products Cc1ccc(C=CC(=O)OC(Cc2ccc(O)c(O)c2)C(=O)O)c(CC(=O)O)c1O UMPZKDHDIZUVTO-UHFFFAOYSA-N 0.000 claims description 3
- KFCMFABBVSIHTB-WUTVXBCWSA-N Salvianolic acid D Chemical compound OC(=O)CC1=C(O)C(O)=CC=C1\C=C\C(=O)O[C@@H](C(O)=O)CC1=CC=C(O)C(O)=C1 KFCMFABBVSIHTB-WUTVXBCWSA-N 0.000 claims description 3
- XLXWKULPMYZQSQ-UHFFFAOYSA-N Salvianolic acid E Natural products Cc1ccc(CC(OC(=O)C(=Cc2ccc(O)c(O)c2)c3c(O)c(O)ccc3C=CC(=O)OC(Cc4ccc(O)c(O)c4)C(=O)O)C(=O)O)cc1O XLXWKULPMYZQSQ-UHFFFAOYSA-N 0.000 claims description 3
- 229930183118 Tanshinone Natural products 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000012982 microporous membrane Substances 0.000 claims description 3
- 238000000874 microwave-assisted extraction Methods 0.000 claims description 3
- 238000012372 quality testing Methods 0.000 claims description 3
- 229930183842 salvianolic acid Natural products 0.000 claims description 3
- 150000004141 diterpene derivatives Chemical class 0.000 claims description 2
- 239000000284 extract Substances 0.000 claims description 2
- 244000037666 field crops Species 0.000 claims description 2
- 229960003371 protocatechualdehyde Drugs 0.000 claims description 2
- 238000013441 quality evaluation Methods 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 238000009331 sowing Methods 0.000 claims description 2
- 239000000463 material Substances 0.000 abstract description 19
- 238000003908 quality control method Methods 0.000 abstract description 11
- 150000007965 phenolic acids Chemical group 0.000 abstract description 5
- 239000000843 powder Substances 0.000 abstract description 4
- 238000001228 spectrum Methods 0.000 abstract 3
- 238000005406 washing Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000000470 constituent Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 241000282470 Canis latrans Species 0.000 description 3
- 241001573881 Corolla Species 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- 241000208340 Araliaceae Species 0.000 description 2
- 241001164374 Calyx Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000207923 Lamiaceae Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 125000000567 diterpene group Chemical group 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- SNKFFCBZYFGCQN-UHFFFAOYSA-N 2-[3-[3-[1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]carbonyl-2-(3,4-dihydroxyphenyl)-7-hydroxy-2,3-dihydro-1-benzofuran-4-yl]prop-2-enoyloxy]-3-(3,4-dihydroxyphenyl)propanoic acid Chemical compound C=1C=C(O)C=2OC(C=3C=C(O)C(O)=CC=3)C(C(=O)OC(CC=3C=C(O)C(O)=CC=3)C(O)=O)C=2C=1C=CC(=O)OC(C(=O)O)CC1=CC=C(O)C(O)=C1 SNKFFCBZYFGCQN-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 244000089742 Citrus aurantifolia Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
- SNKFFCBZYFGCQN-VWUOOIFGSA-N Lithospermic acid B Natural products C([C@H](C(=O)O)OC(=O)\C=C\C=1C=2[C@H](C(=O)O[C@H](CC=3C=C(O)C(O)=CC=3)C(O)=O)[C@H](OC=2C(O)=CC=1)C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 SNKFFCBZYFGCQN-VWUOOIFGSA-N 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- VQKFNUFAXTZWDK-UHFFFAOYSA-N alpha-methylfuran Natural products CC1=CC=CO1 VQKFNUFAXTZWDK-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000004185 countercurrent chromatography Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- -1 diterpene quinones Chemical class 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000010871 livestock manure Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- STCJJTBMWHMRCD-UHFFFAOYSA-N salvianolic acid B Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=O)C=Cc2cc(O)c(O)c3OC(C(C(=O)OC(Cc4ccc(O)c(O)c4)C(=O)O)c23)c5ccc(O)c(O)c5 STCJJTBMWHMRCD-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100401416A CN101040907B (zh) | 2007-04-27 | 2007-04-27 | 扶正化瘀植物药中丹参原料指纹图谱质量检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100401416A CN101040907B (zh) | 2007-04-27 | 2007-04-27 | 扶正化瘀植物药中丹参原料指纹图谱质量检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101040907A CN101040907A (zh) | 2007-09-26 |
CN101040907B true CN101040907B (zh) | 2011-01-05 |
Family
ID=38806836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007100401416A Active CN101040907B (zh) | 2007-04-27 | 2007-04-27 | 扶正化瘀植物药中丹参原料指纹图谱质量检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101040907B (zh) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101078712A (zh) | 2007-04-27 | 2007-11-28 | 上海现代中医药技术发展有限公司 | 扶正化瘀植物药血浆丹参素和丹酚酸b的测定方法 |
CN101042380A (zh) | 2007-04-27 | 2007-09-26 | 上海现代中医药技术发展有限公司 | 扶正化淤植物药血浆五味子乙素的测定方法 |
CN101334386B (zh) | 2007-04-27 | 2012-07-11 | 上海现代中医药股份有限公司 | 扶正化淤植物药血浆苦杏仁苷的测定方法 |
CN101693028B (zh) * | 2009-10-21 | 2012-08-22 | 华东理工大学 | 紫草酸酯类化合物在制备治疗疟疾药物中的应用 |
CN101879229B (zh) * | 2009-12-18 | 2013-03-20 | 上海现代中医药股份有限公司 | 扶正化瘀药物组合物指纹图谱质量检测方法 |
CN101849536A (zh) * | 2010-05-27 | 2010-10-06 | 东北林业大学 | 一种保持采摘后迷迭香茎叶中鼠尾草酸和迷迭香酸含量稳定的方法 |
CN103149310B (zh) * | 2013-01-21 | 2015-05-20 | 贵州景峰注射剂有限公司 | 参芎葡萄糖注射液制剂的指纹图谱建立方法 |
PT3011965T (pt) * | 2013-06-17 | 2020-07-31 | Tasly Pharmaceutical Group Co | Extrato de salvia miltiorrhiza, formulação de micropéletes do mesmo, métodos de preparação do mesmo, e utilizações do mesmo |
CN105277643B (zh) * | 2014-07-17 | 2018-10-30 | 天士力医药集团股份有限公司 | 一种用于复方丹参滴丸的一测多评检测方法 |
CN104374844A (zh) * | 2014-11-13 | 2015-02-25 | 贵州信邦制药股份有限公司 | 丹参药材中水溶性成分的含量测定方法及其应用 |
CN107505425B (zh) * | 2017-07-19 | 2019-08-27 | 山东省分析测试中心 | 一种金鸣片多指标定量指纹图谱的建立方法 |
CN109633009A (zh) * | 2018-12-28 | 2019-04-16 | 广西中医药大学 | 一种丹参及其提取物的质量控制方法 |
CN112946118B (zh) * | 2021-02-01 | 2023-04-07 | 贵州金桥药业有限公司 | 一种药物指纹图谱的测定方法及其指纹图谱 |
CN115561333B (zh) * | 2021-07-02 | 2024-11-22 | 上海百洋制药股份有限公司 | 一种测定血浆中扶正化瘀制剂五种有效成分浓度的方法 |
CN115561327A (zh) * | 2021-07-02 | 2023-01-03 | 上海黄海制药有限责任公司 | 一种测定组织中扶正化瘀制剂紫草酸和大豆苷元浓度的方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1322951A (zh) * | 2001-06-29 | 2001-11-21 | 天津市金士力药物研究开发有限公司 | 丹参药材指纹图谱建立的方法及其标准指纹图谱 |
CN1679871A (zh) * | 2004-03-17 | 2005-10-12 | 天津天士力制药股份有限公司 | 一种复方丹参滴丸质量控制方法 |
-
2007
- 2007-04-27 CN CN2007100401416A patent/CN101040907B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1322951A (zh) * | 2001-06-29 | 2001-11-21 | 天津市金士力药物研究开发有限公司 | 丹参药材指纹图谱建立的方法及其标准指纹图谱 |
CN1679871A (zh) * | 2004-03-17 | 2005-10-12 | 天津天士力制药股份有限公司 | 一种复方丹参滴丸质量控制方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101040907A (zh) | 2007-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101040907B (zh) | 扶正化瘀植物药中丹参原料指纹图谱质量检测方法 | |
Ganesh et al. | Phytochemical analysis of Acanthus ilicifolius and Avicennia officinalis by GC-MS | |
Raina et al. | Andrographis paniculata (Burm. f.) Wall. ex Nees (kalmegh), a traditional hepatoprotective drug from India | |
Chen et al. | Changes in bioactive components related to the harvest time from the spicas of Prunella vulgaris | |
Hosseini et al. | Changes in glycyrrhizin content of Iranian licorice (Glycyrrhiza glabra L.) affected by different root diameter and ecological conditions. | |
Balasubramaniam et al. | Pharmacognostical, physicochemical and phytochemical evaluation of Strobilanthes kunthianus (Acanthaceae) | |
Wang et al. | A review on traditional uses, phytochemistry, pharmacology, toxicology and the analytical methods of the genus Nardostachys | |
CN101078713B (zh) | 一种加入内标物的绞股蓝药材指纹图谱检测方法 | |
He et al. | Bioactive components of the roots of Salvia miltiorrhizae: Changes related to harvest time and germplasm line | |
Mohan et al. | Pharmacognostic and phytochemical investigation of Elephantopus scaber L.(Asteraceae) | |
Khushbu et al. | Paederia foetida Linn. As a potential medicinal plant: A Review | |
Yang et al. | A comparative analysis of the composition of the primary bioactive molecules, antioxidant activities, and anti-inflammation abilities of the roots of Zanthoxylum nitidum harvested at different years of cultivation | |
Mishra et al. | Pharmacognostical and phytochemical evaluation of leaves extract of Jatropha curcas Linn | |
CN101269175B (zh) | 痔舒适洗液的检测方法 | |
CN115039649A (zh) | 一种高品质三七栽培和分选方法 | |
Aron et al. | Pharmacognostic evaluation of stem, leaves and roots of Merremia tridentata (L.) Hallier f. | |
Kim et al. | Effects of forest environments on growth and active compound contents of ligusticum chuanxiong hort. among different forest sites | |
KR102066209B1 (ko) | 당뇨병성 말초신경병증 치료를 위한 한약재 조성물 | |
CN102058685B (zh) | 一种用于止痛消肿的青鹏涂膜剂及其制备方法 | |
Sheng | Cultivation and quality studies of Danshen (Salvia miltiorrhiza) in Australia | |
Li et al. | Eleutherococcus giraldii (Harms) Nakai: a review of botany, traditional uses, phytochemistry, pharmacology and quality control | |
CN101269207A (zh) | 用于防脱生发养发的健脑护发配方 | |
Li et al. | HPLC profiles and biomarker contents of Australian‐grown Salvia miltiorrhiza f. alba roots | |
CN115963197B (zh) | 一种铁筷子药材的质量检测方法 | |
Chopade Atul et al. | PHARMACOGNOSTIC AND PHYTOCHEMICAL EVALUATION OF PHYLLANTHUS FRATERNUS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Huang Zhida Xie Wenkai Document name: Notice of application for publication of patent for invention and entry into the substantive examination procedure |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: SHANGHAI MODERN TCM CO., LTD. Free format text: FORMER NAME: SHANGHAI MODERN CHINESE TRADITIONAL MEDICINE TECHNOLOGY DEVELOPMENT CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 200051 7F-C, 600 lane, Tian Shan Road, Shanghai, Changning District, 4 Patentee after: Shanghai Modern Traditional Chinese Medicine Co., Ltd. Address before: 200051 7F-C, 600 lane, Tian Shan Road, Shanghai, Changning District, 4 Patentee before: Shanghai Modern Chinese Traditional Medicine Technology Development Co., Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: ANHUI ZHIHETANG PHARMACY CO., LTD. Free format text: FORMER OWNER: SHANGHAI MODERN TCM CO., LTD. Effective date: 20140623 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200051 CHANGNING, SHANGHAI TO: 233608 BOZHOU, ANHUI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140623 Address after: 233608 Chengdong Economic Development Zone, Woyang County, Anhui, Bozhou Patentee after: Anhui Zhihetang Pharmacy Co., Ltd. Address before: 200051 7F-C, 600 lane, Tian Shan Road, Shanghai, Changning District, 4 Patentee before: Shanghai Modern Traditional Chinese Medicine Co., Ltd. |